Hamwe nuburyo bwiza bufite ireme, imiterere myiza na serivisi nziza zabakiriya, urukurikirane rwibisubizo byakozwe nisosiyete yacu byoherezwa mubihugu byinshi nakarere k’amasosiyete akora inganda kuri 1- (benzo [d] [1, 3] dioxol-5-yl ) -2-Bromopropan-1-Imwe C10h9bro3 52190-28-0, Niba bishoboka, menya neza ko wohereje ibyo ukeneye hamwe nurutonde rurambuye harimo imiterere / ikintu numubare ukeneye.Tuzahita twohereza ibiciro byacu byo kugurisha cyane.
Hamwe nuburyo bwiza bufite ireme, imiterere myiza na serivisi nziza zabakiriya, urukurikirane rwibisubizo byakozwe nisosiyete yacu byoherezwa mubihugu byinshi no mukarere kuriUbushinwa 2 5-Dimethoxybenzaldehyde na S) -N-Tert-Butoxycarbonyl, Kuba ibisubizo byambere byuruganda rwacu, ibisubizo byibisubizo byageragejwe kandi bidutsindira ibyemezo byuburambe.Kubindi bipimo nibintu byurutonde birambuye, menya neza gukanda buto kugirango ubone amakuru yinyongera.
Methyl (2r, 3s) -n-tert-butoxycarbonyl-3-fenyl isoserinate ikoreshwa nkigihe cya Docetaxel.
Docetaxel irakwiriye kuvura kanseri y'ibere yateye imbere cyangwa metastatike.Docetaxel irakwiriye kuvura kanseri y'ibihaha yateye imbere cyangwa metastatike itari ntoya ya kanseri y'ibihaha, na nyuma yo kunanirwa na chimiotherapie ishingiye kuri cisplatine.
Hamwe nuburyo bwiza bufite ireme, imiterere myiza na serivisi nziza zabakiriya, urukurikirane rwibisubizo byakozwe nisosiyete yacu byoherezwa mubihugu byinshi nakarere k’amasosiyete akora inganda kuri 1- (benzo [d] [1, 3] dioxol-5-yl ) -2-Bromopropan-1-Imwe C10h9bro3 52190-28-0, Niba bishoboka, menya neza ko wohereje ibyo ukeneye hamwe nurutonde rurambuye harimo imiterere / ikintu numubare ukeneye.Tuzahita twohereza ibiciro byacu byo kugurisha cyane.
Inganda zikoraUbushinwa 2 5-Dimethoxybenzaldehyde na S) -N-Tert-Butoxycarbonyl, Kuba ibisubizo byambere byuruganda rwacu, ibisubizo byibisubizo byageragejwe kandi bidutsindira ibyemezo byuburambe.Kubindi bipimo nibintu byurutonde birambuye, menya neza gukanda buto kugirango ubone amakuru yinyongera.